181 related articles for article (PubMed ID: 15696051)
41. Excessively high systemic blood pressure in the early phase of reperfusion exacerbates early-onset paraplegia in rabbit aortic surgery.
Pokhrel B; Hasegawa T; Izumi S; Ohmura A; Munakata H; Okita Y; Okada K
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):400-7. PubMed ID: 20537355
[TBL] [Abstract][Full Text] [Related]
42. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
[TBL] [Abstract][Full Text] [Related]
43. NS-7, a novel Na+/Ca2+ channel blocker, prevents neurologic injury after spinal cord ischemia in rabbits.
Shi E; Kazui T; Jiang X; Washiyama N; Suzuki K; Yamashita K; Terada H
J Thorac Cardiovasc Surg; 2005 Feb; 129(2):364-71. PubMed ID: 15678048
[TBL] [Abstract][Full Text] [Related]
44. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
[TBL] [Abstract][Full Text] [Related]
45. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
[TBL] [Abstract][Full Text] [Related]
46. Inhibition of poly(adenosine diphosphate-ribose) polymerase decreases long-term histologic damage in testicular ischemia-reperfusion injury.
Bozlu M; Coşkun B; Cayan S; Acar D; Aktaş S; Ulusoy E; Akbay E
Urology; 2004 Apr; 63(4):791-5. PubMed ID: 15072913
[TBL] [Abstract][Full Text] [Related]
47. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
[TBL] [Abstract][Full Text] [Related]
48. Erdosteine ameliorates neurological outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord.
Ege E; Ilhan A; Gurel A; Akyol O; Ozen S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):379-86. PubMed ID: 15350559
[TBL] [Abstract][Full Text] [Related]
49. Protective effect of etomidate on spinal cord ischemia-reperfusion injury induced by aortic occlusion in rabbits.
Yu Q; Zhou Q; Huang H; Wang Y; Tian S; Duan D
Ann Vasc Surg; 2010 Feb; 24(2):225-32. PubMed ID: 19748211
[TBL] [Abstract][Full Text] [Related]
50. Esmolol and landiolol, selective beta1-adrenoreceptor antagonists, provide neuroprotection against spinal cord ischemia and reperfusion in rats.
Umehara S; Goyagi T; Nishikawa T; Tobe Y; Masaki Y
Anesth Analg; 2010 Apr; 110(4):1133-7. PubMed ID: 20103544
[TBL] [Abstract][Full Text] [Related]
51. The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion.
Hauser B; Gröger M; Ehrmann U; Albicini M; Brückner UB; Schelzig H; Venkatesh B; Li H; Szabó C; Speit G; Radermacher P; Kick J
Shock; 2006 Jun; 25(6):633-40. PubMed ID: 16721272
[TBL] [Abstract][Full Text] [Related]
52. Preservation of motor function after spinal cord ischemia and reperfusion injury through microglial inhibition.
Smith PD; Bell MT; Puskas F; Meng X; Cleveland JC; Weyant MJ; Fullerton DA; Reece TB
Ann Thorac Surg; 2013 May; 95(5):1647-53. PubMed ID: 23541432
[TBL] [Abstract][Full Text] [Related]
53. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
54. Collaborative therapy with nebivalol and L-NAME for spinal cord ischemia/reperfusion injury.
Seren M; Budak B; Turan N; Parlar AI; Akar F; Ulus AT
Ann Vasc Surg; 2008; 22(3):425-31. PubMed ID: 18466820
[TBL] [Abstract][Full Text] [Related]
55. Effects of vascular endothelial growth factor on ischemic spinal cord injury caused by aortic cross-clamping in rabbits.
Oz Oyar E; Kardeş O; Korkmaz A; Omeroğlu S
J Surg Res; 2009 Jan; 151(1):94-9. PubMed ID: 18599078
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor 1 prevents neuronal cell death and paraplegia in the rabbit model of spinal cord ischemia.
Nakao Y; Otani H; Yamamura T; Hattori R; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jul; 122(1):136-43. PubMed ID: 11436046
[TBL] [Abstract][Full Text] [Related]
57. Cilostazol, a type III phosphodiesterase inhibitor, reduces ischemia/reperfusion-induced spinal cord injury.
Sahin MA; Onan B; Guler A; Oztas E; Uysal B; Arslan S; Demirkilic U; Tatar H
Heart Surg Forum; 2011 Jun; 14(3):E171-7. PubMed ID: 21676683
[TBL] [Abstract][Full Text] [Related]
58. Postconditioning, a series of brief interruptions of early reperfusion, prevents neurologic injury after spinal cord ischemia.
Jiang X; Shi E; Nakajima Y; Sato S
Ann Surg; 2006 Jul; 244(1):148-53. PubMed ID: 16794400
[TBL] [Abstract][Full Text] [Related]
59. Is remote preconditioning as effective as direct ischemic preconditioning in preventing spinal cord ischemic injury?
Gurcun U; Discigil B; Boga M; Ozkisacik E; Badak MI; Yenisey C; Kurtoglu T; Meteoglu I
J Surg Res; 2006 Oct; 135(2):385-93. PubMed ID: 16904694
[TBL] [Abstract][Full Text] [Related]
60. Comparison of the effect of mexiletine and methylprednisolone on neural function and histopathological damage after transient spinal cord ischemia in rabbits.
Kazanci A; Seckin H; Karadeniz U; Kazanci D; Turan S; Kazanci B; Yigitkanli K; Bavbek M
Turk Neurosurg; 2010 Jan; 20(1):43-9. PubMed ID: 20066621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
